Back to User profile » Dr Jifeng Feng
Papers published by Dr Jifeng Feng:
Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets
Lv Y, Ma X, Du Y, Feng J
OncoTargets and Therapy 2021, 14:589-607
Published Date: 22 January 2021
Serum Platelet-Derived Growth Factor Is Significantly Lower in Patients with Lung Cancer and Continued to Decrease After Platinum-Based Chemotherapy
Ma R, Yang Q, Cao S, Liu S, Cao H, Xu H, Wu J, Feng J
OncoTargets and Therapy 2020, 13:1883-1892
Published Date: 4 March 2020
The Role Of Circulating Tumor DNA In Therapeutic Resistance
Xu C, Cao H, Shi C, Feng J
OncoTargets and Therapy 2019, 12:9459-9471
Published Date: 8 November 2019
Glutathione S-transferase π: a potential role in antitumor therapy
Dong S, Sha H, Xu X, Hu T, Lou R, Li H, Wu J, Dan C, Feng J
Drug Design, Development and Therapy 2018, 12:3535-3547
Published Date: 23 October 2018
Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner
Qin X, Yu S, Zhou L, Shi M, Hu Y, Xu X, Shen B, Liu S, Yan D, Feng J
International Journal of Nanomedicine 2017, 12:3721-3733
Published Date: 15 May 2017
Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin
Hu Y, Zang J, Qin X, Yan D, Cao H, Zhou L, Ni J, Yu S, Wu J, Feng JF
OncoTargets and Therapy 2017, 10:2341-2348
Published Date: 28 April 2017
Elevated serum levels of vascular endothelial growth factor predict a poor prognosis of platinum-based chemotherapy in non-small cell lung cancer
Zang JL, Hu Y, Xu XY, Ni J, Yan DL, Liu SW, He J, Xue J, Wu JZ, Feng JF
OncoTargets and Therapy 2017, 10:409-415
Published Date: 18 January 2017